• 參考資料PM-COR-22-112808

    1. Celebrex® (celecoxib) 100 mg, 200 mg & 400 mg Capsules Prescribing Information. Viatris Healthcare Hong Kong: Version August 2022.
    2. Ogbru O. Cox-2 inhibitors. MedicineNet. Available at: https://www.medicinenet.com/cox-2_inhibitors/article.htm. Accessed on February 14, 2023.
    3. Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Eng J Med. 2016;375(26):2519-2529.
    4. Chan FKL, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): A randomised trial. Lancet. 2010;376(9736):173-179.
    5. Hertz. S. FDA Consumer Health Information, US, FDA, September 2015.
    6. Szeto CC, Sugano K, Wang JG, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: Joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut. 2020;69(4):617-629.